Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer

BACKGROUND: Tamoxifen use has been associated with increased risk of thromboembolic events (TEs) in women with breast cancer and women at high risk for the disease. Factor V Leiden (FVL) is the most common inherited clotting factor mutation and also confers increased thrombosis risk. We investigated...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Garber, Judy E., Halabi, Susan, Tolaney, Sara M., Kaplan, Ellen, Archer, Laura, Atkins, James N., Edge, Stephen, Shapiro, Charles L., Dressler, Lynn, Paskett, Electra M., Kimmick, Gretchen, Orcutt, James, Scalzo, Anthony, Winer, Eric, Levine, Ellis, Shahab, Nasir, Berliner, Nancy
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2010
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2897879/
https://ncbi.nlm.nih.gov/pubmed/20554945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djq211
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker